Public Calendar: July 24-30, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 07/25/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Britten Hardie, Erica Johnson, Esther Gifford, Greg Dow, Ralph Clare (Walmart);

Event Date: 07/28/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Brent Cox, Karen McGuire, Kate Meyer, Keith Dailey, Rodney McMullen, Stuart Aitken (Kroger);

Event Date: 07/28/2022
Location: Virtual
Subject: FDA's Priorities and Collaboration
FDA Participant/Group: BETH FRITSCH;
Non FDA Participant/Group: Several members of the Biotechnology Innovation Organization Executive Committee and staff

Event Date: 07/29/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Joseph Scimeca, Michael Dykes (International Dairy Foods Association);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 07/26/2022
Location: Virtual
Subject: Patient-Centered Outcomes Research Institute (PCORI) Board Planning Session
FDA Participant/Group: N/A
Non FDA Participant/Group: Planning Board members

Event Date: 07/26/2022
Location: Washington, DC
Subject: National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Annual National Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, regulatory, and other stakeholders

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 07/28/2022
Location: Virtual
Subject: Monthly FDA / USDA Food Safety and Inspection Service (FSIS) Executive Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several USDA-FSIS staff

Event Date: 07/28/2022
Location: Virtual
Subject: Quarterly FDA / Food and Beverage Issue Alliance (FBIA) Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several FBIA members

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 07/26/2022
Location: Virtual
Subject: National Institute of Allergy and Infectious Diseases (NIAID) Meeting on Tecovirimat (TPOXX)
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from National Institute of Allergy and Infectious Diseases (NIAID)

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 07/26/2022
Location: Virtual
Subject: Monkeypox
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the Association of State and Territorial Health Officials

Event Date: 07/27/2022
Location: Virtual
Subject: Duke Clinical Research Institute - Drug Development for the Top Five Chronic Health Conditions; Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, and patient stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 07/29/2022
Location: Virtual
Subject: CNET Interview; FDA Infant Formula Initiatives and Regulations
FDA Participant/Group: N/A
Non FDA Participant/Group: Jessica Rendall (CNET.com);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event